Dr Reddys Price Prediction and Hype Density Breakdown

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 15px;;'>DR</div>
RDY -- USA Stock  

USD 42.35  0.23  0.54%

We analyze noise-free headlines and recent hype associated with Dr Reddys Laboratories Ltd which may create opportunities for some arbitrage if properly timed. With Dr Reddys hype-based prediction module you can estimate the value of Dr Reddys Laboratories Ltd from the prospective of Dr Reddys response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Dr Reddys over a specific investment horizon. Additionally take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Dr Reddys After-Hype Price Density Analysis

 Next price density 
  Expected price to next headline 

Dr Reddys Estimiated After-Hype Price Volatility

Current Value
January 23, 2020
After-hype Price
Dr Reddys is very steady asset. Analysis and calculation of next after-hype price of Dr Reddys Laboratories is based on 3 months time horizon.

Dr Reddys Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.13  1.21  0.01   0.12  7 Events / Month2 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Dr Reddys Hype Timeline

On the 23th of January Dr Reddys Laboratories is traded for 42.35. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.12. Dr Reddys Laboratories Ltd is estimated to increase in value after the next headline with price going to jump to 42.36. The average volatility of media hype impact on the company stock price is about 1344.44%. The price escalation on the next news is projected to be 0.02% where as daily expected return is at this time at 0.13%. The volatility of related hype on Dr Reddys is about 131.52% with expected price after next announcement by competition of 42.47. The company reported last year revenue of 2.17 B. Total Income to common stockholders was 233.41 M with profit before taxes, overhead, and interest of 83.43 B. Considering 30-days investment horizon, the next estimated press release will be in about 7 days.
Additionally take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections.

Dr Reddys Related Hype Analysis

At Risk
Vertex Pharmaceuticals Incorpor 6.30 8 per month 0.16  0.23  2.80 (1.14)  6.05 
Dr Reddys Laboratories Ltd 0.09 7 per month 0.97  0.0161  2.39 (1.81)  6.20 
Sinovac Biotech Ltd 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis(1.36) 10 per month 1.57  0.02  1.44 (2.02)  8.38 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Perrigo Company Plc 0.60 8 per month 1.51  0.0183  2.79 (1.91)  13.43 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals 3.51 8 per month 1.51  0.09  2.82 (1.84)  12.69 
SciClone Pharmaceuticals, In 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Origin Agritech Limited 0.06 5 per month 3.49  0.08  9.11 (6.94)  58.70 
Additionally take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Company logos by clearbit